Burning Rock Biotech (BNR) Free Cash Flow: 2020-2025
Historic Free Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $2.3 million.
- Burning Rock Biotech's Free Cash Flow rose 114.52% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year increase of 73.37%. This contributed to the annual value of -$13.4 million for FY2024, which is 63.99% up from last year.
- Per Burning Rock Biotech's latest filing, its Free Cash Flow stood at $2.3 million for Q3 2025, which was up 124.31% from -$9.5 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Free Cash Flow registered a high of $2.6 million during Q4 2024, and its lowest value of -$66.2 million during Q4 2022.
- In the last 3 years, Burning Rock Biotech's Free Cash Flow had a median value of -$5.6 million in 2024 and averaged -$6.5 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 313.05% in 2021, then skyrocketed by 215.74% in 2024.
- MRQ analysis of 5 years shows Burning Rock Biotech's Free Cash Flow stood at -$17.6 million in 2021, then plummeted by 275.71% to -$66.2 million in 2022, then surged by 96.59% to -$2.3 million in 2023, then soared by 215.74% to $2.6 million in 2024, then decreased by 11.80% to $2.3 million in 2025.
- Its Free Cash Flow stands at $2.3 million for Q3 2025, versus -$9.5 million for Q2 2025 and -$3.2 million for Q1 2025.